Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy. (2025). Biomolecules and Biomedicine, 25(5), 1099–1110. https://doi.org/10.17305/bb.2024.11217